Ethyl 5-(benzyloxy)-1H-indole-2-carboxylate

Catalog No. :
ACHNFQ485
CAS No. :
37033-95-7
Molecular Formula :
C18H17NO3
Molecular Weight :
295.34

IUPAC Name:ethyl 5-(benzyloxy)-1H-indole-2-carboxylate

Ethyl 5-(benzyloxy)-1H-indole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$68.00Login to see priceIn stockIn stock
25g95%$321.00Login to see priceIn stockIn stock
100g95%$1027.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-(benzyloxy)-1H-indole-2-carboxylate
IUPAC Nameethyl 5-(benzyloxy)-1H-indole-2-carboxylate
MDL No.MFCD00022702
Molecular FormulaC18H17NO3
Molecular Weight295.34
SMILESO=C(C(N1)=CC2=C1C=CC(OCC3=CC=CC=C3)=C2)OCC
InChI KeyDCIFXYFKVKDOLL-UHFFFAOYSA-N
SynonymNSC 30931 | Ethyl 5-(benzyloxy)indole-2-carboxylate | Ethyl 5-(benzyloxy)-1H-indole-2-carboxylate # | A6374 | MFCD00022702 | ethyl 5-phenylmethoxy-1H-indole-2-carboxylate | 5-Benzyloxy-1H-indole-2-carboxylic acid ethyl ester | AS-47522 | Solpirin | AMY318
CAS No.37033-95-7
PubChem CID95721

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H317
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACHNFQ485 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJXQF561 route compound structure diagram
    ACJXQF56124985-85-1 In Stock
  4. Then
  5. ACHNFQ485 route product structure diagram
    ACHNFQ48537033-95-7 In Stock
Inquiry

2. ACHNFQ485 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJXQF561 route compound structure diagram
    ACJXQF56124985-85-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHNFQ485 route product structure diagram
    ACHNFQ48537033-95-7 In Stock
Inquiry

Comments (0)